These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10508983)

  • 1. Recurrent cerebral infarctions and del(10)(p14p15.1) de novo in HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome.
    Fujimoto S; Yokochi K; Morikawa H; Nakano M; Shibata H; Togari H; Wada Y
    Am J Med Genet; 1999 Oct; 86(5):427-9. PubMed ID: 10508983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia) associated with del(10)(p13).
    Hasegawa T; Hasegawa Y; Aso T; Koto S; Nagai T; Tsuchiya Y; Kim KC; Ohashi H; Wakui K; Fukushima Y
    Am J Med Genet; 1997 Dec; 73(4):416-8. PubMed ID: 9415468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction.
    Mejia JD; Cervantes L; Puerta H; Bauer M; Diaz A
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):961-5. PubMed ID: 24859509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor GATA3 and the human HDR syndrome.
    Van Esch H; Devriendt K
    Cell Mol Life Sci; 2001 Aug; 58(9):1296-300. PubMed ID: 11577985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the DiGeorge syndrome region on 10p13/14.
    Lichtner P; König R; Hasegawa T; Van Esch H; Meitinger T; Schuffenhauer S
    J Med Genet; 2000 Jan; 37(1):33-7. PubMed ID: 10633131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDR syndrome with a novel mutation in GATA3 mimicking a congenital X-linked stapes gusher: a case report.
    Yang A; Kim J; Ki CS; Hong SH; Cho SY; Jin DK
    BMC Med Genet; 2017 Oct; 18(1):121. PubMed ID: 29073906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial idiopathic hypoparathyroidism, sensorineural deafness and renal dysplasia.
    Ishida S; Isotani H; Kameoka K; Kishi T
    Intern Med; 2001 Feb; 40(2):110-3. PubMed ID: 11300141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first Korean case of HDR syndrome confirmed by clinical and molecular investigation.
    Cheon CK; Kim GH; Yoo HW
    Yonsei Med J; 2015 Jan; 56(1):300-3. PubMed ID: 25510779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3 abnormalities and the phenotypic spectrum of HDR syndrome.
    Muroya K; Hasegawa T; Ito Y; Nagai T; Isotani H; Iwata Y; Yamamoto K; Fujimoto S; Seishu S; Fukushima Y; Hasegawa Y; Ogata T
    J Med Genet; 2001 Jun; 38(6):374-80. PubMed ID: 11389161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10p12.1 deletion: HDR phenotype without DGS2 features.
    Benetti E; Murer L; Bordugo A; Andreetta B; Artifoni L
    Exp Mol Pathol; 2009 Feb; 86(1):74-6. PubMed ID: 19022243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDR syndrome: a novel "de novo" mutation in GATA3 gene.
    Ferraris S; Del Monaco AG; Garelli E; Carando A; De Vito B; Pappi P; Lala R; Ponzone A
    Am J Med Genet A; 2009 Feb; 149A(4):770-5. PubMed ID: 19248180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The First Turkish Case of Hypoparathyroidism, Deafness and Renal Dysplasia (HDR) Syndrome.
    Döneray H; Usui T; Kaya A; Dönmez AS
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):140-3. PubMed ID: 26316437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel De Novo GATA Binding Protein 3 Mutation in a Turkish Boy with Hypoparathyroidism, Deafness, and Renal Dysplasia Syndrome.
    Yeşiltepe Mutlu G; Kırmızıbekmez H; Nakamura A; Fukami M; Hatun Ş
    J Clin Res Pediatr Endocrinol; 2015 Dec; 7(4):344-8. PubMed ID: 26777049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA3 haplo-insufficiency causes human HDR syndrome.
    Van Esch H; Groenen P; Nesbit MA; Schuffenhauer S; Lichtner P; Vanderlinden G; Harding B; Beetz R; Bilous RW; Holdaway I; Shaw NJ; Fryns JP; Van de Ven W; Thakker RV; Devriendt K
    Nature; 2000 Jul; 406(6794):419-22. PubMed ID: 10935639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial congenital choanal atresia with GATA3 associated hypoparathyroidism-deafness-renal dysplasia syndrome unidentified on auditory brainstem response.
    Kita M; Kuwata Y; Usui T
    Auris Nasus Larynx; 2019 Oct; 46(5):808-812. PubMed ID: 30396722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual Proliferative Glomerulonephritis in a Patient Diagnosed to Have Hypoparathyroidism, Sensorineural Deafness, and Renal Dysplasia (HDR) Syndrome with a Novel Mutation in the GATA3 Gene.
    Kamezaki M; Kusaba T; Adachi T; Yamashita N; Nakata M; Ota N; Shiotsu Y; Ishida M; Usui T; Tamagaki K
    Intern Med; 2017; 56(11):1393-1397. PubMed ID: 28566604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical description of a patient carrying the smallest reported deletion involving 10p14 region.
    Melis D; Genesio R; Boemio P; Del Giudice E; Cappuccio G; Mormile A; Ronga V; Conti A; Imperati F; Nitsch L; Andria G
    Am J Med Genet A; 2012 Apr; 158A(4):832-5. PubMed ID: 22407589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel GATA3 nonsense mutation in a newly diagnosed adult patient of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.
    Nanba K; Usui T; Nakamura M; Toyota Y; Hirota K; Tamanaha T; Kawashima ST; Nakao K; Yuno A; Tagami T; Naruse M; Shimatsu A
    Endocr Pract; 2013; 19(1):e17-20. PubMed ID: 23186964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and mutational spectrum of hypoparathyroidism, deafness and renal dysplasia syndrome.
    Belge H; Dahan K; Cambier JF; Benoit V; Morelle J; Bloch J; Vanhille P; Pirson Y; Demoulin N
    Nephrol Dial Transplant; 2017 May; 32(5):830-837. PubMed ID: 27387476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA3 abnormalities in six patients with HDR syndrome.
    Fukami M; Muroya K; Miyake T; Iso M; Kato F; Yokoi H; Suzuki Y; Tsubouchi K; Nakagomi Y; Kikuchi N; Horikawa R; Ogata T
    Endocr J; 2011; 58(2):117-21. PubMed ID: 21242646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.